Dr Reddy's Laboratories launches Fenofibrate Tablets in US
Health

Dr Reddy's Laboratories launches Fenofibrate Tablets in US

Agency News

Hyderabad, Apr 27: Dr Reddy’s Laboratories Limited along with its subsidiaries on Monday announced the launch of Fenofibrate Tablets USP, a therapeutic equivalent generic version of Tricor (fenofibrate) Tablets, approved by the US Food and Drug Administration (USFDA).

The Tricor brand and generic had US sales of approximately USD 90 million MAT for the most recent 12 months ending in January 2020 according to IQVIA Health, a company statement here said.

Dr Reddy’s Fenofibrate Tablets USP, are available in 54 mg dose in bottle count size of 90 and 160 mg dose in bottle count sizes of 90 and 500, the statement added.(UNI)

pennews
www.pennews.net